First Time Loading...

Theseus Pharmaceuticals Inc
NASDAQ:THRX

Watchlist Manager
Theseus Pharmaceuticals Inc Logo
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Watchlist
Price: 4.06 USD Market Closed
Updated: May 13, 2024

Theseus Pharmaceuticals Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theseus Pharmaceuticals Inc
Operating Expenses Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Operating Expenses
-$54.1m
CAGR 3-Years
-122%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Operating Expenses
-$35.3B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Expenses
-$24.1B
CAGR 3-Years
2%
CAGR 5-Years
-23%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Operating Expenses
-$28.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Operating Expenses
-$39.8B
CAGR 3-Years
-27%
CAGR 5-Years
-17%
CAGR 10-Years
-8%
Eli Lilly and Co
NYSE:LLY
Operating Expenses
-$17.5B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-4%

See Also

What is Theseus Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-54.1m USD

Based on the financial report for Dec 31, 2022, Theseus Pharmaceuticals Inc's Operating Expenses amounts to -54.1m USD.

What is Theseus Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-122%

Over the last year, the Operating Expenses growth was -98%. The average annual Operating Expenses growth rates for Theseus Pharmaceuticals Inc have been -122% over the past three years .